Medicine and Dentistry
Absence
10%
Acute Coronary Syndrome
13%
All Cause Mortality
7%
Anticoagulation
9%
Antithrombotic
7%
Apoplexy
21%
Arteriosclerosis Obliterans
11%
Atrial Fibrillation
27%
Brain Ischemia
34%
Cardiology
11%
Cardiovascular Disease
39%
Cardiovascular Risk
46%
Cardiovascular System
47%
Cause of Death
20%
CHA2DS2-VASc Score
7%
Chronic Kidney Disease
10%
Cohort Analysis
32%
Cooperation
16%
Coronary Angiography
33%
Coronary Artery Disease
82%
Coronary Computed Tomography Angiography
7%
Diabetes
58%
Diabetes Mellitus
26%
Disease
12%
Drug-Eluting Stent
41%
Hazard Ratio
32%
Heart Death
21%
Heart Failure
12%
Heart Muscle Ischemia
26%
Heart Muscle Revascularization
9%
Ischemic Heart Disease
15%
Major Adverse Cardiac Event
13%
Maturity Onset Diabetes of the Young
16%
Mortality
8%
Myocardial Infarction
100%
Noncardiac Surgery
14%
Odds Ratio
13%
Patient with Diabetes
17%
Percutaneous Coronary Intervention
38%
Population
30%
Primary Percutaneous Coronary Intervention
17%
Prophylaxis
7%
Rapamycin
10%
Rheumatoid Arthritis
10%
Risk Stratification
7%
ST Segment Elevation Myocardial Infarction
20%
Stable Angina Pectoris
7%
Statin
12%
Stent Thrombosis
14%
Zotarolimus
10%
Pharmacology, Toxicology and Pharmaceutical Science
Absence
8%
Acetylsalicylic Acid
15%
Acute Heart Infarction
7%
All Cause Mortality
17%
Anticoagulant Agent
12%
Atrial Fibrillation
27%
Autoimmune Disease
5%
Bleeding
6%
Brain Ischemia
41%
Cardiovascular Disease
33%
Cardiovascular Disease
10%
Cardiovascular Mortality
5%
Cardiovascular Risk
58%
Cause of Death
15%
Chronic Kidney Failure
10%
Cohort Study
32%
Coronary Artery Atherosclerosis
20%
Coronary Artery Disease
98%
Diabetes Mellitus
17%
Disease
19%
Heart Death
19%
Heart Failure
20%
Heart Infarction
94%
Heart Muscle Ischemia
23%
High Density Lipoprotein Cholesterol
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Ischemic Heart Disease
20%
Low Density Lipoprotein Cholesterol
6%
Monotherapy
5%
Non Insulin Dependent Diabetes Mellitus
17%
Peripheral Occlusive Artery Disease
7%
Retrospective Study
6%
Rheumatoid Arthritis
10%
Rivaroxaban
6%
ST Segment Elevation Myocardial Infarction
27%
Stable Angina Pectoris
8%
Statin (Protein)
18%
Stent Thrombosis
7%
Thromboembolism
5%
Ticagrelor
5%
Keyphrases
10-year Mortality
6%
All-cause Mortality
7%
Anticoagulation Strategy
5%
Autoimmune Disease
5%
Baseline Risk
5%
Cardiovascular Outcomes
5%
Cardiovascular Risk Assessment
5%
Chronic Coronary Syndrome
5%
Confidence Interval
5%
Coronary Artery Disease
5%
Coronary Atherosclerosis
5%
Coronary Stent Implantation
5%
Denmark
11%
Dual Pathway Inhibition
5%
Ejection Fraction
5%
Heart Failure
5%
Individual Participant Data
5%
Ischemic Events
5%
Left Ventricular Ejection Fraction
5%
Left Ventricular Function
5%
Lower Extremity Revascularization
5%
Myocardial Infarction
5%
National Health Registry
5%
Net Clinical Benefit
5%
Newly Diagnosed
5%
Non-obstructive
5%
Optical Coherence Tomography
5%
Pooled Cohorts
5%
Population-based
5%
Registry Study
5%
Registry-based
5%
Strong Predictor
5%
Sudden Cardiac Death
5%
Thrombus
5%
Type 2 Diabetes Mellitus (T2DM)
5%
